Addex Therapeutics (ADXN)

Addex Therapeutics (ADXN) Stock Price & Analysis


ADXN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.55 - $5.45
Previous Close$1.13
Average Volume (3M)336.37K
Market Cap
Enterprise Value$9.01M
Total Cash (Recent Filing)SFr.10.43M
Total Debt (Recent Filing)SFr.447.11K
Price to Earnings (P/E)-0.3
Mar 30, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.56
Shares Outstanding19,224,718
10 Day Avg. Volume183,053
30 Day Avg. Volume336,373
Standard Deviation0.29
Financial Highlights & Ratios
Price to Book (P/B)2.53
Price to Sales (P/S)26.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest stock price was $0.55 and its highest was $5.45 in the past 12 months.
    What is Addex Therapeutics’s market cap?
    Currently, no data Available
    When is Addex Therapeutics’s upcoming earnings report date?
    Addex Therapeutics’s upcoming earnings report date is Mar 30, 2023 which is tomorrow.
      How were Addex Therapeutics’s earnings last quarter?
      Addex Therapeutics released its earnings results on Nov 11, 2022. The company reported $0.571 earnings per share for the quarter, beating the consensus estimate of -$0.093 by $0.664.
        Is Addex Therapeutics overvalued?
        According to Wall Street analysts Addex Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Addex Therapeutics pay dividends?
          Addex Therapeutics does not currently pay dividends.
          What is Addex Therapeutics’s EPS estimate?
          Addex Therapeutics’s EPS estimate is -$0.05.
            How many shares outstanding does Addex Therapeutics have?
            Addex Therapeutics has 19,224,718 shares outstanding.
              What happened to Addex Therapeutics’s price movement after its last earnings report?
              Addex Therapeutics reported an EPS of $0.571 in its last earnings report, beating expectations of -$0.093. Following the earnings report the stock price went up 1.299%.
                Which hedge fund is a major shareholder of Addex Therapeutics?
                Among the largest hedge funds holding Addex Therapeutics’s share is New Leaf Venture Partners, L.L.C.. It holds Addex Therapeutics’s shares valued at N/A.


                  Addex Therapeutics Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Addex Therapeutics

                  Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Crispr Therapeutics AG
                  ADC Therapeutics
                  AC Immune SA

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis